We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$61.8B
AUM Growth
+$7.3B
Cap. Flow
+$3.47B
Cap. Flow %
5.61%
Top 10 Hldgs %
15.31%
Holding
2,670
New
59
Increased
1,417
Reduced
325
Closed
89

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$106M
2
NXPI icon
NXP Semiconductors
NXPI
+$93.6M
3
BABA icon
Alibaba
BABA
+$90M
4
XOM icon
ExxonMobil
XOM
+$83.7M
5
CHTR icon
Charter Communications
CHTR
+$82.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.13%
2 Technology 14.52%
3 Consumer Staples 10.68%
4 Consumer Discretionary 10.21%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRCY icon
1701
Mercury Systems
MRCY
$6.7B
$1.53M ﹤0.01%
61,500
+8,000
+15% +$172K
MMSI icon
1702
Merit Medical Systems
MMSI
$5.45B
$1.52M ﹤0.01%
76,800
+4,600
+6% +$88.4K
XLRN
1703
DELISTED
Acceleron Pharma
XLRN
$1.52M ﹤0.01%
44,800
+1,000
+2% +$32.5K
BCC icon
1704
Boise Cascade
BCC
$2.94B
$1.52M ﹤0.01%
66,200
TLN
1705
DELISTED
Talen Energy Corporation
TLN
$1.52M ﹤0.01%
112,076
-23,700
-17% -$290K
BEL
1706
DELISTED
Belmond Ltd.
BEL
$1.51M ﹤0.01%
153,000
WIN
1707
DELISTED
Windstream Holdings Inc
WIN
$1.51M ﹤0.01%
32,680
-1,880
-5% -$80.2K
KEX icon
1708
Kirby Corp
KEX
$7.18B
$1.51M ﹤0.01%
24,257
-500
-2% -$32.7K
FINL
1709
DELISTED
Finish Line
FINL
$1.51M ﹤0.01%
74,900
-1,800
-2% -$34K
CPXX
1710
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$1.51M ﹤0.01%
+50,100
New +$1.02M
PFGC icon
1711
Performance Food Group
PFGC
$16.9B
$1.5M ﹤0.01%
+55,700
New +$1.41M
WSFS icon
1712
WSFS Financial
WSFS
$4.15B
$1.5M ﹤0.01%
46,500
LDRH
1713
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$1.5M ﹤0.01%
40,500
+1,400
+4% +$39.7K
BJRI icon
1714
BJ's Restaurants
BJRI
$1.48B
$1.5M ﹤0.01%
34,100
+400
+1% +$17.7K
IPCC
1715
DELISTED
Infinity Property & Casualty C
IPCC
$1.49M ﹤0.01%
18,500
MBI icon
1716
MBIA
MBI
$254M
$1.49M ﹤0.01%
218,100
CUB
1717
DELISTED
Cubic Corporation
CUB
$1.49M ﹤0.01%
37,100
+800
+2% +$32.5K
WSTC
1718
DELISTED
West Corporation
WSTC
$1.49M ﹤0.01%
75,730
GPRO icon
1719
GoPro
GPRO
$106M
$1.48M ﹤0.01%
+137,300
New +$1.52M
ENLC
1720
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$1.48M ﹤0.01%
93,223
+17,100
+22% +$244K
ACHN
1721
DELISTED
Achillion Pharmaceuticals
ACHN
$1.48M ﹤0.01%
189,100
+3,600
+2% +$30.9K
TNC icon
1722
Tennant Co
TNC
$1.18B
$1.47M ﹤0.01%
27,300
SRPT icon
1723
Sarepta Therapeutics
SRPT
$1.94B
$1.47M ﹤0.01%
77,100
+2,400
+3% +$44.5K
MAG
1724
DELISTED
MAG Silver
MAG
$1.47M ﹤0.01%
117,100
RSTI
1725
DELISTED
Rofin-Sinar Technologies Inc
RSTI
$1.46M ﹤0.01%
45,700

Similar funds

Swiss National Bank's Q2 2016 Portfolio in Review

As of Q2 2016, Swiss National Bank held 2,670 positions worth $61.8B, up 13% from $54.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Swiss National Bank deployed $3.47B of net new capital in Q2 2016, opening 59 new positions and adding to 1,417 existing holdings. Its largest new stake was Under Armour Class C: 522,612 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Kimberly-Clark, an estimated $19.6M trimmed.

  • Swiss National Bank's largest Q2 2016 buy was Under Armour Class C: 522,612 shares worth $19M.
  • Swiss National Bank added most to Apple in Q2 2016, an estimated $106M increase.
  • Swiss National Bank's biggest Q2 2016 reduction was Kimberly-Clark, cutting an estimated $19.6M.
  • Swiss National Bank fully exited Brookfield in Q2 2016, selling an estimated $162M.
  • Swiss National Bank's ten largest holdings make up 15% of its $61.8B portfolio in Q2 2016.
  • Swiss National Bank opened 59 new positions and closed 89 in Q2 2016.
  • Swiss National Bank's portfolio value rose 13% quarter-over-quarter to $61.8B.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.